Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Irajizad E, Wu R, Vykoukal J, Murage E, Spencer R, Dennison JB, Moulder S, Ravenberg E, Lim B, Litton J, Tripathym D, Valero V, Damodaran S, Rauch GM, Adrada B, Candelaria R, White JB, Brewster A, Arun B, Long JP, Do KA, Hanash S, Fahrmann JF.
Irajizad E, et al. Among authors: adrada b.
Front Artif Intell. 2022 Aug 11;5:876100. doi: 10.3389/frai.2022.876100. eCollection 2022.
Front Artif Intell. 2022.
PMID: 36034598
Free PMC article.